ArticleOncotarget2016

Defining the transcriptional and biological response to CDK4/6 inhibition in relation to ER+/HER2- breast cancer.

Erik S Knudsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.